Change in Ratings
(AHL - Get Report) upgraded at Goldman Sachs to buy from neutral based on valuation. See attractive risk/reward profile with shares trading at 0.87 times last reported book value.
American International Group
(AIG - Get Report) downgraded at Goldman to neutral from buy based on balance sheet pressures and dilutive capital raises. See lower investment income and higher general insurance accident-loss ratios. Price target cut to $45 from $59.
(CMC - Get Report) initiated at UBS with buy rating. Price target starts at $37 and fiscal year 2008 EPS estimates begin at $2.05.
(DLTR - Get Report)
upgraded at JPMorgan to neutral from underweight. Most of the negative catalysts have played out since the CFO left last October.
downgraded at Credit Suisse from outperform to neutral with a $73.50 price target. Rumored acquisition by
more than 50% likely to happen, but the potential price remains unclear.
upgraded at JPMorgan from neutral to overweight. Valuation call, especially as fundamentals improved in the first quarter.
downgraded at Morgan Stanley from equal-weight to underweight with a $38 price target. Do not expect ASCO data to meet expectations. Erbitux sales estimates also cut.
(MKL - Get Report)
downgraded at Goldman Sachs to sell from neutral based on view that shares will underperform peers as investors flock to beaten down names with lower multiples.
Marsh & McLennan
upgraded at Goldman Sachs to neutral from sell based on improving sentiment towards turnaround efforts. Note investors are giving management the benefit of the doubt.